ACTUATE THERAPEUTICS INC has a total of 30 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are SOLIPHARMA LLC, HANGZHOU SOLIPHARMA CO LTD and SICHUAN CREDIT PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Brazil | 4 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Israel | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Yamin | 14 |
#2 | Giles Francis | 4 |
#3 | Mazar Andrew | 4 |
#4 | Tucker Torry A | 3 |
#5 | Idell Steven | 3 |
#6 | Yamin Zhang | 2 |
#7 | Steven Idell | 1 |
#8 | Andrew Mazar | 1 |
#9 | Torry A Tucker | 1 |
#10 | Francis Giles | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020123813A1 | Immunohistochemical staining for gsk-3 | |
AU2019280693A1 | Methods of treating malignant lymphoproliferative disorders | |
AU2019271285A1 | Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form beta inhibitors | |
EP3697794A1 | Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5h-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione | |
AU2018313259A1 | solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione |